Contact Kirby McInerney LLP for Securities Class Action Lawsuit Information

The law firm Kirby McInerney LLP is urging investors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) to take action by January 5, 2026, to be considered for the lead plaintiff position in a class action lawsuit. The lawsuit is on behalf of investors who bought Inspire securities between August 6, 2024, and August 4, 2025, a period referred to as the Class Period.

According to the lawsuit, it is alleged that Defendants misrepresented or failed to disclose key information during the Class Period. It is claimed that there was poor demand for Inspire, an implantable medical device used for treating obstructive sleep apnea. The lawsuit suggests that providers had excess inventory and were hesitant to adopt the new treatment. Additionally, it is claimed that despite assurances from Defendants about a successful launch, Inspire Medical had not completed essential tasks necessary for a smooth rollout.

On August 4, 2025, the Company announced that the rollout of Inspire V was delayed due to various issues, such as incomplete training and billing failures at treatment centers. This news led to a decline in Inspire shares by approximately 32.35%. The Company also revised its earnings guidance substantially downward, further affecting investor confidence.

If you have purchased Inspire securities during the specified period, or possess relevant information about the case, you are encouraged to contact Lauren Molinaro at Kirby McInerney LLP to discuss your rights at no cost.

Kirby McInerney LLP is a renowned New York-based law firm that specializes in securities, antitrust, whistleblower, and consumer litigation. The firm has a proven track record of securing significant recoveries for shareholders in various securities-related lawsuits.

It is essential that affected investors take appropriate action before the deadline to ensure they are considered for the lead plaintiff position in this class action lawsuit. More details about the investigation and the lead plaintiff process can be obtained by contacting the provided resources.

Please note that this communication may be considered Attorney Advertising under the applicable law and ethical rules in certain jurisdictions.